Online Inquiry

Small Molecule Biosensor Development Service

Due to its unique advantages, the CRISPR-Cas system has been used to develop biosensors. CD BioSciences, a premier biotechnology company, is committed to providing you with small molecule biosensor development service based on the CRISPR-Cas system.

CRISPR-Cas System-Based Small Molecule Biosensor

CRISPR-Cas System-Based Small Molecule Biosensor

In the life sciences, almost every cell contains hundreds of different organic molecules that play a key role in interspecies information exchange, cellular metabolism and regulation of transcriptional processes. In addition, many small molecules are contaminants of food and the environment. Therefore, the qualitative analysis and quantitative detection of small molecules are particularly important.

  • Principle of CRISPR-Cas System-Based Small Molecule Biosensor Development
    The CRISPR-Cas system is an adaptive immune defense system for bacteria and archaea. It can be used not only for gene editing but also for signal conversion by functional DNA (nucleic acid aptamer or DNAase) and thus for detection of non-nucleic acid targets, showing great potential for small molecule detection. Therefore, small molecule biosensors based on the CRISPR-Cas system can be developed.
  • Examples of CRISPR-Cas System-Based Small Molecule Biosensors
    Several small molecule biosensing systems based on CRISPR-Cas technology have already been developed. For example, CaT-SMelor, an efficient detection system for small molecules based on the trans cleavage activity of CRISPR-Cas12a, which can be used for disease biomarker and contaminated soil sample detection, was established by coupling immobilized aTF, using a fluorescent reporter system.

Our Services

Utilizing the CRISPR-Cas system's ability to specifically identify and incidentally cleave nucleic acid sequences, CD BioSciences offers small molecule biosensor development service. In addition, we also provide services for the detection of various analytes such as nucleic acids, protein biomarkers, metal ions, and small molecules.

Our DeteCasTM platform offers different strategies in small molecule biosensor development service, including but not limited to the followings.

Design of Identification Components   Selection of Cas Effector Proteins
Transcription factors and functional nucleic acids can serve as recognition elements for CRISPR biosensors that specifically recognize and bind target small molecules. We can design different recognition elements according to your detection needs to improve recognition efficiency.   High quality Cas effector proteins are the basis for establishing high performance CRISPR-Cas biosensing systems. We can screen Cas effector proteins with excellent recognition efficiency and shear activity for you and shorten the detection time.
     
Optimization of gRNA Design   Design of Efficient Signal Reporter Molecules
The gRNA sequence characteristics and design location are critical factors in determining the specificity, loading, shear activity and stability of the CRISPR-Cas biosensing system. We can design different gRNA sequences for the gene targets of different nucleic acids to be tested to improve the detection specificity.   We can provide to design efficient signal reporter molecules based on the shear preferences of different Cas effector proteins, which facilitates the sensitivity of the sensing system.

Applications

Food Safety Detection

Food Safety Detection

Disease Diagnosis

Disease Diagnosis

Environmental Monitoring

Environmental Monitoring

Process of Our Service

Process of Our Service

 Advantages of Our Service

• High Flexibility

Only the given gRNA sequence needs to be changed for different gene targets.

• High Specificity

Single-base resolution detection of biosensors is fully possible.

• High Sensitivity

Target analytes can be detected at concentrations as low as 10-18 mol/L.

CD BioSciences provides affordable, qualified and hassle-free small molecule biosensor development service to our global clients. We guarantee on-time delivery of results. We are available to you 24 hours a day, so please feel free to contact us.

References

  1. Liang, M.D., et al. A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules. Nature Communications. 2019, 10: 3672.
  2. Xiong, Y., et al. Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets. Journal of the American Chemical Society. 2020, 1(142): 207-213.
For research use only. Not intended for any clinical use.

Online Inquiry

Related Services

Copyright © CD BioSciences. All rights reserved.